Ovid Therapeutics (NASDAQ: OVID)
$3.10
(3.7%)
$0.11
Price as of April 26, 2024, 4:00 p.m. ET
Ovid Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ovid Therapeutics Company Info
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
News & Analysis
Featured Article
Why Ovid Therapeutics Stock Is Imploding Today
The company reported disappointing results from a late-stage clinical trial.
Prosper Junior Bakiny | Dec 2, 2020
Featured Article
3 Top Biotech Stocks to Buy Now
Here are the best biotech stocks for investors looking for market-beating performance.
Zhiyuan Sun | Jul 25, 2020
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.